[1] |
王晖, 康迪, 周学东 , 等. 微生态调节技术在感染性疾病预防中的应用. 华西口腔医学杂志, 2018,36(5):564-567.
|
[2] |
Isolauri E . Microbiota and obesity. Nestle Nutr Inst Workshop Ser, 2017,88:95-105.
|
[3] |
Fang H, Li D, Kang J , et al. Metabolic engineering of Escherichia coli for de novo biosynthesis of vitamin B12. Nat Commun, 2018,9(1):4917.
|
[4] |
Harmsen HJ, de Goffau MC . The human gut microbiota. Adv Exp Med Biol, 2016,902:95-108.
|
[5] |
Rautava S . Microbial composition of the initial colonization of newborns. Nestle Nutr Inst Workshop Ser, 2017,88:11-21.
|
[6] |
Tennyson CA, Friedman G . Microecology, obesity, and probiotics. Curr Opin Endocrinol Diabetes Obes, 2008,15(5):422-427.
|
[7] |
Chassaing B, Raja SM, Lewis JD , et al. Colonic microbiota encroachment correlates with dysglycemia in humans. Cell Mol Gastroenterol Hepatol, 2017,4(2):205-221.
|
[8] |
Horta-Baas G, Romero-Figueroa MDS, Montiel-Jarquín AJ , et al. Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis. J Immunol Res, 2017,2017:4835189.
|
[9] |
陈硕, 聂汉祥, 刘琳琳 , 等. 肠道菌群与支气管哮喘. 国际呼吸杂志, 2018,38(2):129-132.
|
[10] |
Gopalakrishnan V, Spencer CN, Nezi L , et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science, 2018,359(6371):97-103.
|
[11] |
Matson V, Fessler J, Bao R , et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science, 2018,359(6371):104-108.
|
[12] |
Routy B, Le Chatelier E, Derosa L , et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science, 2018,359(6371):91-97.
|
[13] |
Maji A, Misra R, Dhakan DB , et al. Gut microbiome contri-butes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers. Environ Microbiol, 2018,20(1):402-419.
|
[14] |
Khan N, Vidyarthi A, Nadeem S , et al. Alteration in the gut microbiota provokes susceptibility to tuberculosis. Front Immunol, 2016,7:529.
|
[15] |
Kaufmann SHE . Indole propionic acid: a small molecule links between gut microbiota and tuberculosis. Antimicrob Agents Chemother, 2018, 62(5).pii:e00389-18.
|
[16] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09.
|
[17] |
Li B, Yao Q, Zhu H . Approach to analyze the diversity of myxobacteria in soil by semi-nested PCR-denaturing gradient gel electrophoresis (DGGE) based on taxon-specific gene. PLoS One, 2014,9(10):e108877.
|
[18] |
Yasuhara M, Hunt G, Cronin TM , et al. Temporal latitudinal-gradient dynamics and tropical instability of deep-sea species diversity. Proc Natl Acad Sci U S A, 2009,106(51):21717-21720.
|
[19] |
Pearl JE, Das M, Cooper AM . Immunological roulette: Luck or something more? Considering the connections between host and environment in TB. Cell Mol Immunol, 2018,15(3):226-232.
|
[20] |
Luo M, Liu Y, Wu P , et al. Alternation of gut microbiota in patients with pulmonary tuberculosis. Front Physiol, 2017,8:822.
|
[21] |
Sandberg J, Kovatcheva-Datchary P, Björck I , et al. Abundance of gut Prevotella at baseline and metabolic response to barley prebiotics. Eur J Nutr, 2019,58(6):2365-2376.
|
[22] |
Kovatcheva-Datchary P, Nilsson A, Akrami R , et al. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab, 2015,22(6):971-982.
|
[23] |
Sood U, Bajaj A, Kumar R , et al. Infection and microbiome: impact of tuberculosis on human gut microbiome of indian cohort. Indian J Microbiol, 2018,58(1):123-125.
|
[24] |
Namasivayam S, Maiga M, Yuan W , et al. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome, 2017,5(1):71.
|